Cure8 news brief
Cure8 news brief
A majority of surveyed IBD patients who use marijuana reported better quality of life and relief from symptoms such as nausea, joint pain, insomnia and anxiety — findings of interest to people seeking symptom management options.
Adults with Crohn’s disease or ulcerative colitis, patients with nausea/pain/insomnia/anxiety, clinicians treating IBD, and researchers studying cannabis for symptom control.
The study is based on self-reported experiences from current cannabis users recruited at a single center, so results may reflect selection and positive-response bias rather than objective changes in disease activity. The authors note limitations including small sample size, lack of non-user controls, and absence of objective measures of inflammation.
If you use or are considering cannabis, discuss it with your care team — few participants recalled receiving information about drug interactions, and cannabis can interact with prescription medications.
Survey data were self-reported and recruited from a single center of current marijuana users, which can produce positive-response and selection bias; the study did not include objective measures of disease activity.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.